Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 2 min ago
Peer-reviewedLicence not statedGlobal Health & Medicine

Association of steatotic liver disease with long-term oncological outcomes after hepatic resection for hepatocellular carcinoma

  • Nobuhiro Hasui1,2
  • Saori Funakoshi1,3
  • Aya Yamazaki1
  • Takuya Yanase1
  • Shohei Kudo1
  • Hirokazu Momose1
  • Ryota Matsuki1
  • Masaharu Kogure1
  • Akimasa Hayashi3
  • Yutaka Suzuki4
  • Junji Shibahara3
  • Yoshihiro Sakamoto1
4 affiliations
  1. 1Department of Gastroenterological Surgery, Kyorin University School of Medicine, Mitaka, Tokyo, Japan
  2. 2Division of Hepato-Biliary and Pancreatic Surgery, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan
  3. 3Department of Pathology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan
  4. 4Department of Surgery, Kyorin University Suginami Hospital, Tokyo, Japan.
Read full textPDFDOICite

Related

  1. Association between the preoperative C-reactive protein-albumin-lymphocyte index and prognosis after hepatic resection for hepatocellular carcinoma
    Tomonari Shimagaki, Atsushi Maeda, Tomoya Harima +7
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologySurgery & anaesthesiaPLOS
  2. Association between alpha-fetoprotein elevation and recurrence in patients who achieved normalized alpha-fetoprotein after curative resection for hepatocellular carcinoma : A retrospective cohort study
    Jeong Ah Hwang, Jisun Lee, Kyung Sik Yi +3
    MedicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMCPMC
  3. The CYB5R3–mARC1 Redox Axis in Metabolic Dysfunction-associated Steatotic Liver Disease: Mechanistic Basis and Therapeutic Prospects across the Steatosis–Cirrhosis–Hepatocellular Carcinoma Spectrum
    Journal of Clinical and Translational HepatologyPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  4. Revisiting alpha-fetoprotein thresholds for hepatocellular carcinoma surveillance in the metabolic dysfunction-associated steatotic liver disease era: time for an evidence-based recalibration.
    Miguel Suárez, Raquel Gómez-Molina, Ana M Torres +1
    Journal of gastrointestinal oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  5. Peri-interventional neutrophil extracellular traps and immune surveillance in hepatocellular carcinoma: mechanisms, biomarkers, and recurrence after liver resection or thermal ablation
    Hang Xu, Jiayang Yi, Wanwan Zhang +2
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC

Cite

BibTeXRIS
BibTeX
@article{hasui2026association,
  title = {{Association of steatotic liver disease with long-term oncological outcomes after hepatic resection for hepatocellular carcinoma}},
  author = {Nobuhiro Hasui and Saori Funakoshi and Aya Yamazaki and Takuya Yanase and Shohei Kudo and Hirokazu Momose and Ryota Matsuki and Masaharu Kogure and Akimasa Hayashi and Yutaka Suzuki and Junji Shibahara and Yoshihiro Sakamoto},
  journal = {Global Health \& Medicine},
  year = {2026},
  month = oct,
  doi = {10.35772/ghm.2026.01056},
  url = {https://doi.org/10.35772/ghm.2026.01056},
}
RIS
TY  - JOUR
TI  - Association of steatotic liver disease with long-term oncological outcomes after hepatic resection for hepatocellular carcinoma
AU  - Nobuhiro Hasui
AU  - Saori Funakoshi
AU  - Aya Yamazaki
AU  - Takuya Yanase
AU  - Shohei Kudo
AU  - Hirokazu Momose
AU  - Ryota Matsuki
AU  - Masaharu Kogure
AU  - Akimasa Hayashi
AU  - Yutaka Suzuki
AU  - Junji Shibahara
AU  - Yoshihiro Sakamoto
PY  - 2026
DA  - 2026/10/31
JO  - Global Health & Medicine
DO  - 10.35772/ghm.2026.01056
UR  - https://doi.org/10.35772/ghm.2026.01056
SN  - 2434-9186
SN  - 2434-9194
ER  -